 | |
| Clinical data | |
|---|---|
| Trade names | Fluonex, Lidex, others[1] |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601054 |
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Liver |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.005.998 |
| Chemical and physical data | |
| Formula | C26H32F2O7 |
| Molar mass | 494.532 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Fluocinonide is a potentglucocorticoid usedtopically as ananti-inflammatory agent for the treatment ofskin disorders such aseczema andseborrhoeic dermatitis.[2] It relievesitching, redness,dryness, crusting, scaling,inflammation, and discomfort.[2]
A common potential adverse effect is skin atrophy (thinning of the skin).[3]
In 2022, it was the 266th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[4][5]
Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs.[6] Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure.[7]
